Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling

Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways

(2013) Zheng Zhang et al.   BASIC RESEARCH IN CARDIOLOGY

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism

(2012) Xiaolin Niu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic Rats

(2012) Dongdong Sun et al.   PLoS One

Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation

(2011) Juan P. Aragón et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade

(2011) Sajoscha A. Sorrentino et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nebivolol prevents remodeling in a rat myocardial infarction model: an echocardiographic study

(2010) Guldem Olguner Mercanoglu et al.   Anadolu Kardiyoloji Dergisi-The Anatolian Journal of Cardiology

Toll-like receptor 4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation

(2010) Zheng Zhang et al.   INFLAMMATION RESEARCH